This inventor holds 8 USPTO granted patents. Top assignees: Sk&f Lab Co., Imperial Chemical Industries Limited, Smithkline Corporation. Active years: 1976-1995.
Company Filing History:
3 out of 11 
2 out of 3,840 
2 out of 344 Years Active: 1976-1995
Title: **The Innovative Journey of Joseph J. Lewis**
Introduction
Joseph J. Lewis, based in West Chester, PA, is a noteworthy inventor with a remarkable portfolio of 8 patents. His contributions primarily focus on neuropsychiatric disorders, showcasing his commitment to advancing pharmaceutical sciences.
Latest Patents
Among his latest inventions, Lewis developed piperidine derivatives which are represented by compounds of formula I, Ia, or Ib, along with their pharmaceutically acceptable salts. These compounds are crucial for treating neuropsychiatric disorders such as psychoses. Additionally, he has devised pharmaceutical compositions that include these compounds and methods for administering effective doses to mammals, including humans. His innovative work demonstrates significant potential in enhancing treatments for mental health conditions.
Career Highlights
Throughout his career, Joseph J. Lewis has collaborated with notable companies, including SmithKline Corporation and Schering-Plough Lab Co. His roles in these organizations have allowed him to apply his expertise in real-world settings, pushing the boundaries of pharmaceutical research.
Collaborations
Lewis has worked alongside esteemed colleagues such as Robert L. Webb and Diane A. Trainor. Their collaborations have been instrumental in driving forward their shared goals in pharmaceutical innovation and research.
Conclusion
Joseph J. Lewis exemplifies the spirit of innovation in the pharmaceutical field, with a dedicated focus on developing solutions for critical neuropsychiatric disorders. His contributions through his eight patents highlight the importance of research and collaboration in bringing transformative ideas to life.